SAMSUNG BIOLOGICS Co., Ltd. (207940) Revenue

1 Followers

SAMSUNG BIOLOGICS Co., Ltd. Revenue

SAMSUNG BIOLOGICS Co., Ltd. had a revenue of 1.32T in the quarter ending Jun 30, 2026, with 5.07%. This bring the company's revenue in the last twelve months to 4.55T, Decreased 0.69%. In the fiscal year ending Dec 31, 2025, SAMSUNG BIOLOGICS Co., Ltd. had annual revenue of 4.56T with 30.31% growth.

Revenue (ttm)

4.55T

Revenue Growth

-9.64%

P/S Ratio

13.88

Revenue/Employee

₩835,375,196

Employees

5,455

Market Cap

₩63.23T

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	4.56T	1.06T	+30.31%
Dec 31, 2024	3.50T	-197.44B	-5.34%
Dec 31, 2023	3.69T	693.29B	+23.10%
Dec 31, 2022	3.00T	1.43T	+91.41%
Dec 31, 2021	1.57T	403.23B	+34.62%
Dec 31, 2020	1.16T	463.19B	+66.02%
Dec 31, 2019	701.59B	165.79B	+30.94%
Dec 31, 2018	535.81B	71.18B	+15.32%
Dec 31, 2017	464.63B	―	―